Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Preventive Medicine|February 1, 2020
Human Papillomavirus 16/18-Associated Cervical Lesions: Differences by Area-Based Measures of Race and PovertyMonica M Brackney, Julia W Gargano, Susan E Hannagan, et al.
The Journal of Infectious Diseases|February 8, 2017
Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014Julia W Gargano, Elizabeth R Unger, Gui Liu, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 19, 2021
An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in MichiganJulia W Gargano, Mei You, Rachel Potter, et al.
Sexually Transmitted Diseases|June 23, 2025
Association between high-risk HPV prevalence and circumcision status among sexually experienced adult males, 2013-2016, United StatesRayleen M Lewis, Sarah K Brewer, Julia W Gargano, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
The Journal of Infectious Diseases|September 22, 2017
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014Sara E Oliver, Elizabeth R Unger, Rayleen Lewis, et al.
The Journal of Infectious Diseases|June 23, 2021
Prevalence of Human Papillomavirus Among Women Older than Recommended Age for Vaccination by Birth Cohort, United States 2003‒2016Kristin Vahle, Julia W Gargano, Rayleen M Lewis, et al.
Sexually Transmitted Diseases|January 25, 2021
Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United StatesRayleen M Lewis, Jean-François Laprise, Julia W Gargano, et al.
Plos One|December 6, 2022
Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studiesMegan Wallace, Jennifer P Collins, Heidi Moline, et al.
Pageof 5